参考文献/References:
[1] OU G J,WANG J,JI X,et al.A study of HLA-B*15:02 in 9 different Chinese ethnics:Implications for carbamazepine related SJS/TEN[J].HLA,2017,89(4):225-229.
[2] HE Xiaojing,JIAN Lingyan,HE Xiaolin,et al.Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China[J].PharmacologicalReports,2013,65(5):1256-1262.
[3] HSIAO Y H,HUI RC,WU T,et al.Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions:strength and clinicalcorrelations[J].Journal of Dermatological Science,2014,73(2):101-109.
[4] CHONG K W,CHAN D W,CHEUNG Y B,et al.Association of carbamazepine-induced severe cutaneous drug reactions and HLA-B*1502 allele status,and dose andtreatment duration in paediatric neurology patients in Singapore[J].Archivesof Disease in Childhood,2014,99(6):581-584.
[5] KULKANTRAKORN K,TASSANEEYAKUL W,TIAMKAO S,et al.HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxicepidermal necrolysis in Thai patients with neuropathic pain[J].Pain Pract,2012,12(3):202-208.
[6] 高婷婷,龙琴.Stevens-Johnson综合征和中毒性表皮坏死松解症发病机制的研究进展[J].中华眼科杂志,2016,52(9):708-713.
GAO Tingting,LONG Qin.Recent progress in research of pathogenesesof Stevens-Johnson syndrome and toxic epidermal necrolysis[J].Chin J Ophthalmol,2016,52(9):708-713.
[7] THEN SM,RANI ZZ,RAYMOND AA,et al.Frequency of the HLA-B*1502 allelecontributing to carbamazepine-induced hypersensitivity reactions in a cohort ofMalaysian epilepsy patients[J].Asian Pacific Journal of Allergy and Immunology,2011,29(3):290-293.
[8] ELZAGALLAAI AA,GARCIABOURNISSEN F,FI-NKELSTEIN Y,et al.Severe bullous hypersensitivity reactions after exposure to carbamazepine in a Han-Chinese child with a positive HLA-B*1502 and negative in vitro toxicity assays: evidence for different pathophysiological mechanisms[J].J Popul Ther Clin Pharmacol,2011,18(1):e1-9.